For those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering.

Uncover the potential of DOXIMITY INC-CLASS A (NYSE:DOCS), a growth stock that our stock screener found to be reasonably priced. NYSE:DOCS is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation. We'll examine each aspect in detail.

Assessing Growth for NYSE:DOCS

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NYSE:DOCS has received a 8 out of 10:

• The Earnings Per Share has grown by an impressive 21.62% over the past year.
• The Earnings Per Share has been growing by 106.72% on average over the past years. This is a very strong growth
• DOCS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.57%.
• DOCS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.27% yearly.
• The Earnings Per Share is expected to grow by 13.19% on average over the next years. This is quite good.
• DOCS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.62% yearly.

Valuation Examination for NYSE:DOCS

ChartMill assigns a Valuation Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing different valuation elements, such as price to earnings and free cash flow, both in absolute terms and relative to the market and industry. In the case of NYSE:DOCS, the assigned 6 reflects its valuation:

• Based on the Price/Earnings ratio, DOCS is valued cheaper than 92.31% of the companies in the same industry.
• Based on the Price/Forward Earnings ratio, DOCS is valued cheaply inside the industry as 87.18% of the companies are valued more expensively.
• DOCS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DOCS is cheaper than 84.62% of the companies in the same industry.
• Based on the Price/Free Cash Flow ratio, DOCS is valued cheaply inside the industry as 84.62% of the companies are valued more expensively.
• The excellent profitability rating of DOCS may justify a higher PE ratio.
• A more expensive valuation may be justified as DOCS's earnings are expected to grow with 14.05% in the coming years.

How do we evaluate the Health for NYSE:DOCS?

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NYSE:DOCS scores a 9 out of 10:

• DOCS has an Altman-Z score of 23.26. This indicates that DOCS is financially healthy and has little risk of bankruptcy at the moment.
• With an excellent Altman-Z score value of 23.26, DOCS belongs to the best of the industry, outperforming 94.87% of the companies in the same industry.
• DOCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
• A Current Ratio of 8.03 indicates that DOCS has no problem at all paying its short term obligations.
• Looking at the Current ratio, with a value of 8.03, DOCS belongs to the top of the industry, outperforming 89.74% of the companies in the same industry.
• A Quick Ratio of 8.03 indicates that DOCS has no problem at all paying its short term obligations.
• With an excellent Quick ratio value of 8.03, DOCS belongs to the best of the industry, outperforming 89.74% of the companies in the same industry.

Assessing Profitability for NYSE:DOCS

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NYSE:DOCS has achieved a 9:

• DOCS's Return On Assets of 13.76% is amongst the best of the industry. DOCS outperforms 97.44% of its industry peers.
• Looking at the Return On Equity, with a value of 15.92%, DOCS belongs to the top of the industry, outperforming 97.44% of the companies in the same industry.
• Looking at the Return On Invested Capital, with a value of 15.40%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
• The Average Return On Invested Capital over the past 3 years for DOCS is significantly above the industry average of 4.85%.
• DOCS has a better Profit Margin (29.39%) than 97.44% of its industry peers.
• In the last couple of years the Profit Margin of DOCS has grown nicely.
• Looking at the Operating Margin, with a value of 34.75%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
• DOCS's Operating Margin has improved in the last couple of years.
• DOCS's Gross Margin of 88.94% is amongst the best of the industry. DOCS outperforms 97.44% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Check the latest full fundamental report of DOCS for a complete fundamental analysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.